Pulmopres

Product Description

Pulmopres is a pharmaceutical formulation containing Tadalafil as its active component, which functions as a phosphodiesterase type 5 inhibitor. This therapeutic agent is principally indicated for managing erectile dysfunction and alleviating symptoms associated with benign prostatic hyperplasia.

Uses

Pulmopres is prescribed for male patients experiencing erectile dysfunction, facilitating the attainment and sustenance of erections sufficient for sexual intercourse. Additionally, it is employed to address manifestations of benign prostatic hyperplasia (BPH), including urinary hesitancy, diminished urinary stream, and urinary frequency or urgency.

How to Use

Administer Pulmopres orally, with or without meals, in accordance with medical advice. For erectile dysfunction management, the medication may be taken either on an as-needed basis prior to sexual activity or as a daily regimen. It is imperative to adhere to the maximum dosage limit of one tablet per 24-hour period.

How it Works

The active constituent Tadalafil operates by enhancing penile blood circulation, thereby facilitating erection. This mechanism involves relaxation of smooth muscle tissue in the prostate and bladder, which concurrently ameliorates BPH symptoms.

Benefits

Pulmopres offers significant therapeutic advantages by effectively addressing erectile dysfunction, thereby enhancing sexual performance. Furthermore, it provides symptomatic relief for BPH, including improvement in urinary initiation, stream strength, and reduction in urinary frequency and urgency.

Common Side Effects

Adverse reactions may include cephalalgia, gastrointestinal discomfort, dorsalgia, myalgia, nasal congestion, facial flushing, or vertigo. Persistent or aggravated symptoms warrant immediate medical consultation.

Dosage and Administration

The initial recommended dosage for as-needed use is 10 mg, to be consumed prior to anticipated sexual activity. Dosage adjustments within the range of 5 mg to 20 mg may be implemented based on individual therapeutic response and tolerability.

Warnings

Pulmopres is contraindicated in patients with cardiovascular conditions, hepatic insufficiency, or renal impairment. Hypersensitivity to Tadalafil constitutes an absolute contraindication. A comprehensive medical evaluation is essential prior to initiating therapy.

Storage

Maintain Pulmopres at ambient temperature, protected from thermal extremes and direct sunlight. Cryopreservation is only permissible when specified in the accompanying documentation. Ensure secure storage away from pediatric and animal access.